文章参考来源:
PureTech Health Inks Deal with Boehringer Ingelheim for Immuno-Oncology
https://www.biospace.com/article/puretech-health-inks-deal-with-boehringer-ingelheim-for-immuno-oncology/
*声明:本文由入驻新浪医药新闻作者撰写,观点仅代表作者本人,不代表新浪医药新闻立场。文章参考来源:
PureTech Health Inks Deal with Boehringer Ingelheim for Immuno-Oncology
https://www.biospace.com/article/puretech-health-inks-deal-with-boehringer-ingelheim-for-immuno-oncology/
*声明:本文由入驻新浪医药新闻作者撰写,观点仅代表作者本人,不代表新浪医药新闻立场。
小编推荐:
勃林格/礼来启动SGLT2抑制
莎普爱思获醋酸钠林格注
勃林格殷格翰与Bridge Bio
勃林格-礼来重磅SGLT2抑制